Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review

doi:10.4251/wjgo.v11.i5.367

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9793)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

599

WORD

238

HTML

5082

Figures (1-3)

310

Tables (1-2)

303

Sum=6532

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

615

Download

887

Sum=1502

Publishing Process of This Article

Item

Count

Browse

771

Download

988

Sum=1759

May 15, 2019 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. May 15, 2019; 11(5): 367-376
Published online May 15, 2019. doi: 10.4251/wjgo.v11.i5.367

Full Size Figure Download Figure

Figure 3 Complete response 9 months after transarterial chemoembolization and stereotactic body radiation therapy. A: Contrast-enhanced computed tomography (CT) arterial phase; B: Contrast-enhanced CT venous phase; C: Magnetic resonance imaging with liver-specific contrast agent.

Citation: Gerum S, Jensen AD, Roeder F. Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review. World J Gastrointest Oncol 2019; 11(5): 367-376
URL: https://www.wjgnet.com/1948-5204/full/v11/i5/367.htm
DOI: https://dx.doi.org/10.4251/wjgo.v11.i5.367